Ewing's Sarcoma (ES) Recruiting Phase 2 Trials for DB08881 (Vemurafenib)

Also known as: Ewing's Sarcoma / Ewing sarcoma / Ewings Sarcoma / Sarcoma, Ewing's / Sarcoma, Ewing / Sarcoma, Ewings / Ewing's sarcoma NOS / Ewing's sarcoma stage unspecified / Ewing's tumor / Ewing's tumour

IndicationStatusPhase
DBCOND0086609 (Ewing's Sarcoma (ES))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03220035Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Treatment